Anthony Fauci. Photo: Getty ImagesCOVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month. Others will begin in August, September and October, the US government's top infectious diseases expert have said. The news comes as Moderna Inc, which is at the forefront of the country's vaccine development efforts, reiterated earlier in the day that a late-stage trial with 30,000 volunteers would begin this month. Earlier today, Dr Francis Collins, the director of the US National Institutes of Health, said the Trump administration's vaccine-acceleration program could generate a safe and effective COVID-19 vaccine by year-end.

Source: Otago Daily Times July 02, 2020 20:15 UTC